Navigation Links
The leading edge of stress: New genomic, optogenetic and epigenetic findings
Date:11/15/2011

Washington Research released today uses the latest genetic tools to explore how stress alters brain function, leading to anxiety, depression, and other stress-related mood disorders. The research was presented at Neuroscience 2011, the Society for Neuroscience's annual meeting and the world's largest source of emerging news about brain science and health.

Stress has many meanings; in neuroscience stress is generally defined as any kind of change that causes physical or psychological strain. Today's findings provide more clues as to how different kinds of stress alter genes and brain function clues that may explain behavior and mood changes in stress-related disorders.

Specifically, the research released today shows that:

  • Brain cells that produce serotonin may be critical for stress to affect mood and behavior. Researchers found that "silencing" serotonin cells blocked increased fear behaviors in stressed mice (Michael Baratta, PhD, abstract 719.07, see attached summary).

  • An extra copy of a single gene, general transcription factor II-I (GTF2I), is linked to separation anxiety in both mice and humans (Lucy Osborne, PhD, abstract 901.28, see attached summary).

  • The effects of prenatal stress can be passed across generations in male mice. The study suggests that epigenetics are to blame for disruptions in male brain development in mice that experienced prenatal stress and their offspring (Christopher Morgan, abstract 190.02, see attached summary).

Another recent finding discussed shows that:

  • Female mice with a modification in the serotonin transporter gene are particularly vulnerable to prenatal stress. This finding suggests that vulnerability to emotional disorders is determined by a complex interaction of genes and environment, including prenatal stress (Sissi Jakob, MSc, see attached speaker's summary).

"Specific types of stress are a serious risk factor for many psychiatric and physical illnesses, including quite common ones such as depression and heart disease," said Klaus A. Miczek, PhD, of Tufts University, press conference moderator and an expert on social stressors and the brain. "Understanding the underlying mechanisms of stress will help identify novel targets for treating these illnesses, thus improving the health and lives of millions of people."


'/>"/>

Contact: Kat Snodgrass
ksnodgrass@sfn.org
Society for Neuroscience
Source:Eurekalert

Related biology news :

1. Evolution offers clues to leading cause of death during childbirth
2. Misleading morphology: 3 European parasitoid wasp species are seasonal forms of just 1
3. SomaLogic announces agreement with leading global pharma company to accelerate R&D
4. National labs leading charge on building better batteries
5. Joslin researchers identify pathways leading to activation of good fat
6. Firewood movement leading cause of oak infestation in San Diego County
7. John Theurer Cancer Center researchers shared 14 leading edge studies at recent ASCO meeting
8. Editor-in-chief of leading robotics journal responds to Obamas robotics initiative
9. UC Riverside licenses leading South African company to market GEM avocados
10. UCSB urban ecosystem research featured in leading ecology journal
11. All wrapped up: K-State researchers graphene cloak protects bacteria, leading to better images
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... , Jan 20, 2017 Research and ... Biometrics Market 2017-2021" report to their offering. ... The global voice recognition biometrics ... 2017-2021. The report covers the present scenario and ... 2017-2021. To calculate the market size, the report considers the revenue ...
(Date:1/18/2017)...  In vitro diagnostic (IVD) companies were very active ... and Kalorama Information expects that trend to continue – ... Generally, uncertainty in reimbursement and healthcare reform in ... the acquisitions landscape. Instead of looking to buy technology, ... outside of their home country and also to increase ...
(Date:1/12/2017)...  Trovagene, Inc. (NASDAQ: TROV ), a ... that it has signed agreements with seven strategic partners ... Middle East for commercialization of the ... wave of international distribution agreements for Trovagene,s CLIA based ... The initial partners will introduce Trovagene,s liquid biopsy ...
Breaking Biology News(10 mins):
(Date:2/17/2017)... , Feb. 17, 2017  Protagonist Therapeutics, ... data on its oral peptide drug candidates, PTG-100 ... of the European Crohn,s and Colitis Organization (ECCO).  ... Barcelona, Spain from February 15 ... detail preclinical data on Protagonist drug candidates PTG-100 ...
(Date:2/16/2017)... Arbor, MI (PRWEB) , ... February 16, 2017 , ... ... 5:00-7:00 p.m. The event will be held at Avomeen Analytical Services (4840 Venture ... by a MichBio member organization. They provide an opportunity to interact with peers, make ...
(Date:2/16/2017)... and GREENWICH, Conn. ... private investment firm focused on venture growth investments ... promotion of Josh Richardson , M.D. to ... investments in biotechnology companies.  He is a board ... important roles in Longitude,s investments in Aimmune Therapeutics, ...
(Date:2/16/2017)... 2017  ArmaGen, Inc., a privately held biotechnology ... severe neurological disorders, today reported preliminary evidence of ... company,s investigational therapy for the treatment of Hurler ... I, or MPS I). The initial results from ... today at the 13 th annual WORLD ...
Breaking Biology Technology: